Cargando…
Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer
Colorectal cancer (CRC) is one of the most common and lethal human malignancies worldwide; however, the therapeutic outcomes in the clinic still are unsatisfactory due to the lack of effective and safe therapeutic regimens. Orally administrable and CRC-targetable drug delivery is an attractive appro...
Autores principales: | Ying, Kangkang, Bai, Bingjun, Gao, Xing, Xu, Yuzi, Wang, Hangxiang, Xie, Binbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293278/ https://www.ncbi.nlm.nih.gov/pubmed/34307319 http://dx.doi.org/10.3389/fbioe.2021.670124 |
Ejemplares similares
-
Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer
por: Bai, Bingjun, et al.
Publicado: (2021) -
Editorial: Oral Nanotherapeutics for Colon Diseases
por: Duan, Lian, et al.
Publicado: (2021) -
Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer
por: Hou, Lidan, et al.
Publicado: (2022) -
Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis
por: Lin, Meisi, et al.
Publicado: (2021) -
Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
por: Qu, Xiaoying, et al.
Publicado: (2023)